Cancer Registration: Incidence, treatment and survival time of lung sarcomatoid cancer in England (2004-2017)

• Published by: Public Health England
• Last updated: 21 February 2020
• Topic: Health
• Licence: Open Government Licence

Summary

National Cancer Registration And Analysis Service (NCRAS). (2020).Cancer Registration: Incidence and treatment of lung sarcomatoid cancer in England (2004-2017) [Data set]. Public Health England. https://doi.org/10.25503/7yv2-wa53

This data set contains patient level data for sarcomatoid lung cancer in England between the years 2004 to 2017. Cancers included in the dataset are: lung (C34) with the following five histological subtypes: Pleomorphic carcinoma (ICD-0) 8022/3, Giant cell carcinoma 8031/3, Spindle cell carcinoma 8032/3, Carcinosarcoma 8980/3 and Pulmonary blastoma 8972/3.

Whenever it is possible and practicable to do so, data released by PHE will be anonymous and made available under an Open Government License. To render the data anonymous it must be stripped of direct identifiers and privacy by design methods applied in line with the rules layed out in the ISB Anonymisation Standard for Publishing Health and Social Care Data Specification (2013).

More from this publisher

All datasets from Public Health England

Related datasets

• Cancer Registration: Epidemiology of lung cancer tumours in England 2009 to 2013
• Incidence of lung cancer(all)
• Cancer Registration: Cancer Incidence in England (1971-2016)
• Cancer Registration: Incidence of female breast cancer in London, 2002 - 2017

Search

Data links

Link to the data	Format	File added	Data preview
Cancer Registration: Incidence, treatment and survival time of lung sarcomatoid cancer in England (2004-2017)	N/A	21 February 2020	Not available

Contact

Freedom of Information (FOI) requests

PHE Public Accountability

Edit this dataset

You must have an account for this publisher on data.gov.uk to make any changes to a dataset.